Evidence map›Paper›PMID 42041864›Full record

ArticleJournal of xenobiotics2026

Insecticides Promote Inflammation and Gut Barrier Alteration in In-Vitro Human Models.

Carlos Sanchez-Martin, Mariagrazia D'Agostino, Stefano Miglietta, Veronica Cocetta, Luna Laera, Isabella Giacomini, Martina Lanza, Marica Mennini, Maria Maddalena Storelli, Ettore Cicinelli and 2 more

Abstract read
In one paragraph

Article in Journal of xenobiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carlos Sanchez-MartinDepartment of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0001-5223-4798
Mariagrazia D'AgostinoDepartment of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.ORCID 0000-0001-6127-9656
Stefano MigliettaDepartment of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.ORCID 0000-0002-7755-2028
Veronica CocettaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, 35131 Padova, Italy.ORCID 0000-0002-0350-8403
Luna LaeraDepartment of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.ORCID 0000-0002-5266-1156
Isabella GiacominiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, 35131 Padova, Italy.
Martina LanzaDepartment of Experimental Medicine, University of Salento, Via per Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-7608-4026
Marica MenniniDepartment of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.
Maria Maddalena StorelliDepartment of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.ORCID 0000-0003-1425-1073
Ettore CicinelliSecond Unit of Obstetrics and Gynecology, Department of Biomedical and Human Oncological Science, Università degli Studi di Bari Aldo Moro, Piazza Giulio Cesare 1, 70124 Bari, Italy.ORCID 0000-0003-2390-4582
Monica MontopoliDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, 35131 Padova, Italy.ORCID 0000-0001-6182-4132
Alessandra CastegnaDepartment of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.

Funding

Fondazione Umberto Veronesi VC was supported by Fondazione Umberto VeronesiNational Operational Programme (PON) "Research and Innova-tion" 2014-2020 CSM was supported by a fixed-term research position funded by the National Operational Pro-gramme (PON) "Research and Innova-tion" 2014-2020, Action IV.6 - Green research projects, co-financed by the European Social Fund (ESF) FSE REACT-EU, D.M. n.1062, 1
6 · The paper itself

Abstract

backgroundThe extensive use of insecticides in modern agriculture has raised concerns about potential chronic effects on human health beyond acute toxicity. Limited evidence exists regarding their impact on immune regulation and intestinal barrier integrity, two key components of host-environment interactions.

methodsHuman in-vitro models were used to investigate the immunomodulatory and intestinal effects of several commonly used agricultural insecticides. Primary human macrophages derived from peripheral blood mononuclear cells were exposed to insecticides to assess cell viability and polarization status. Intestinal barrier function was evaluated using Caco-2 cell monolayers by measuring oxidative stress, epithelial integrity, paracellular permeability, and tight junction organization.

resultsThe tested insecticides induced a pro-inflammatory macrophage phenotype, characterized by increased expression of M1 markers and reduced M2 markers, without affecting cell viability. In Caco-2 cells, insecticide exposure compromised epithelial barrier integrity and disrupted tight junction organization. In this context, neither Spinetoram nor Spirotetramat induced notable oxidative stress under pro-oxidant conditions. However, Spirotetramat caused a significant increase in paracellular permeability.

conclusionsThese findings indicate that commonly used insecticides can modulate immune responses and impair intestinal barrier function, suggesting potential mechanisms by which chronic low-level exposure may contribute to immune dysregulation and epithelial dysfunction in humans.

Indexed as

barrier integrityinflammationinsecticidespro-inflammatory macrophagestight junction organization

Identifiers

PMID42041864
PMCPMC13117409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.